Arcturus Therapeutics Holdings Inc. Common Stock

ARCTNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
6.05 USD
↘ 0.13 (2.10%)AT CLOSE (11:59 AM EDT)
6.05
↘ 0.01 (0.08%)
POST MARKET (AS OF 05:00 PM EDT)
Post Market
AS OF 05:00 PM EDT
6.05
↘ 0.01 (0.08%)
🔴Market: CLOSED

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) trades at $6.06 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jul 17, 2026.

Open?$6.09
High?$6.18
Low?$6.00
Prev. Close?$6.18
Volume?429.6K
Avg. Volume?503.5K
VWAP?$6.08
Rel. Volume?0.85x
Bid / Ask
Bid?$5.23 × 100
Ask?$7.10 × 100
Spread?$1.87
Midpoint?$6.17
Valuation & Ratios
Market Cap?175.7M
Shares Out?28.4M
Float?22.8M
Float %?80.1%
P/E Ratio?N/A
P/B Ratio?0.92
EPS?-$2.77
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsBiotech - Drug Development›Infectious Disease & Vaccines
Employees
111
Market Cap
175.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.arcturusrx.com
Listed
2013-05-22
Address
10285 SCIENCE CENTER DRIVE
SAN DIEGO, CA
Phone: (858) 900-2660
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
10
Short Sent.?
30
Piotroski F-Score?2/9Weak
Altman Z-Score?-1.21Distress
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?29.87%Squeeze Risk
Short Interest?6.8M
Days to Cover?15.5
Free Float22.8M
Avg Daily Volume439.7K
Settlement Date2026-06-30
Financial Health
Current Ratio?6.31Strong
Quick Ratio?6.31Strong
Cash Ratio?6.15Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.92CHEAP▾
P/S?
Peers
100
S&P
48
3.21FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.4CHEAP▾
EV/Sales?
S&P
97
-0.65CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-41.1%WEAK▾
ROA?
S&P
3
-32.1%WEAK▾
Cash Flow & Enterprise
FCF?$-58667000
Enterprise Value?$-35720434
Fundamentals ratios updated end of day
MarketsMoversWatchlist